The largest database of trusted experimental protocols

Pgl3 dual luciferase reporter vector

Manufactured by Promega
Sourced in United States

The PGL3 Dual-Luciferase Reporter Vector is a plasmid designed for the evaluation of gene expression and regulation in mammalian cells. It contains two luciferase reporter genes: firefly (Photinus pyralis) and Renilla (Renilla reniformis) luciferase. The firefly luciferase gene serves as the primary reporter, while the Renilla luciferase gene provides an internal control for normalization.

Automatically generated - may contain errors

9 protocols using pgl3 dual luciferase reporter vector

1

Unveiling the HOXA3-miR-338-3p Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to predictions made using the TargetScan database (release 7.2; http://www.targetscan.org), a putative miR-338-3p-binding site was identified in the 3′-untranslated region (3′-UTR) of the HOXA3 gene. The HOXA3 wild-type (WT) 3′-UTR sequence and a mutant version (MT) were amplified via PCR and cloned into the pGL3 dual-luciferase reporter vector (Promega Corporation) to create pGL3-HOXA3-3′-UTR-WT (WT vector) and pGL3-HOXA3-3′-UTR-MT (MT vector). Source of the DNA was human HOXA3 cDNA; polymerase: Pyrobest DNA polymerase (Fermentas; Thermo Fisher Scientific, Inc.). The primers used were: WT, forward, 5′-CCGCTCGAGGAGCCAGGAGTCACTAGG-3′, and reverse, 5′-TAAGCGGCCGCTTGTTTTCAGAACGTGAG-3′. The PCR settings were 94°C for 3 min; 35 cycles at 94°C for 30 sec, 55°C for 30 sec and 72°C for 30 sec; terminated at 72°C for 5 min. SUP-T1 cells in the logarithmic growth phase were seeded into 96-well plates at 1.5×104 cells/well, and co-transfected with the 100 ng WT or 100 ng MT vector and one of the 50 nM miRNA or 150 nM inhibitor (miR-338-3p mimics, NC, miR-338-3p inhibitor or inhibitor NC) using Attractene Transfection Reagent (Qiagen, Inc.). Following incubation for 48 h, the ratio of firefly to Renilla luciferase activity was determined using a dual-luciferase reporter system, according to the manufacturer's protocols (Promega Corporation).
+ Open protocol
+ Expand
2

Validating miR-498 Binding Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Firstly, online software has validated the putative binding sites between miR-498 and AFAP1-AS1 or VEGFA using LncBase Predicted v.2.0 (http://carolina.imis.athena-innovation.gr/) and starBase v2.0 (http://starbase.sysu.edu.cn/mirCircRNA.php). In order to further confirm the relationships among them, we used Dual-luciferase reporter assay. Wild type AFAP1-AS1 fragments (AFAP1-AS1 WT) containing miR-498 binding sites or AFAP1-AS1 mutant sequence (AFAP1-AS1 MUT) without miR-498 binding sites was inserted into the pGL3 dual-luciferase reporter vector (Promega, Madison, WI, USA). After that, the dual-luciferase reporter plasmid of AFAP1-AS1 WT or AFAP1-AS1 MUT was co-transfected into Eca109 and KYSE-30 cells with NC mimics or miR-498 mimic by using Lipofectamine 3000 (Invitrogen). After transfection for 24 hrs, the relative luciferase activity was measured with the use of a dual-luciferase reporter assay system (Promega, Madison, WI, USA). Similarly, wild or mutant VEGFA 3ʹUTR sequence containing miR-498 binding sites or not was cloned into the pGL3 dual-luciferase reporter vector to form the reporter vectors VEGFA WT and VEGFA MUT.
+ Open protocol
+ Expand
3

Dual-Luciferase Reporter Assay for XIST and TRIB2

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sequence of XIST or TRIB2 was synthesized and cloned into the pGL3 Dual-luciferase reporter vector (Promega, Madison, MI, U.S.A.). The generated new reporter vectors were named as pGL3-XIST-WT (wild-type of XIST), pGL3-XIST-Mut (mutant-type of XIST), pGL3-TRIB2-WT (wild-type of TRIB2) and pGL3-TRIB2-Mut (mutant-type of TRIB2), respectively. The pGL3-XIST-WT and pGL3-TRIB2-WT contained the predicted binding sites of miR-125b-5p. Above reporter vectors were co-transfected into AMC-HN-8 and M4E cells with miR-NC or miR-125b-5p mimic using Lipofectamine® 2000. After 48 h, the relative luciferase activity was examined using a Dual-luciferase Reporter Assay kit (Promega), normalized to that of Renilla.
+ Open protocol
+ Expand
4

EGFR Expression Regulation by miR-4429

Check if the same lab product or an alternative is used in the 5 most similar protocols
The binding sequences of miR-4429 to the 3’-UTR region of EGFR were predicted in starBase v2.0 platform (http://starbase.sysu.edu.cn/). The wild-type (WT)-EGFR sequence containing the miR-4429 binding site and mutant-type (MUT)-EGFR sequence was cloned into the pGL3 dual-luciferase reporter vector (Promega, Madison, WI, USA). Then, the WTEGFR and MUTEGFR vectors were co-transfected with miR-4429 mimic or mimic negative control (NC) into HEK293T cells using Lipofectamine 3000 reagent (Invitrogen, CA, USA) following the manufacturer’s instructions. The results were examined after 48 hours.
+ Open protocol
+ Expand
5

Luciferase Assay for miR-185-5p Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
The luciferase reporter plasmids constructed by inserting the wild-type(wt) linc00958/RSF-1 segments targeted by miR-185-5p or mutant(mt) counterparts onto pGL3 dual luciferase reporter vector (Promega, Shanghai, China). The plasmids included pGL3-linc00958-wt, pGL3-linc00958-mt, pGL3-RSF-1-wt and pGL3-RSF-1-mt. The indicated luciferase plasmids were transfected into SiHa/DDP cells with the miR-185-5p mimics and mimics NC using Lipo8000 kit (Beyotime). After 48 h, luciferase activity was measured on a multi-functional microplate reader after applying Dual Lumi Luciferase reporter Gene Assay kit (Beyotime). The experiments were performed in triplicate.
+ Open protocol
+ Expand
6

Validation of miR-146a-5p Binding to GPR17

Check if the same lab product or an alternative is used in the 5 most similar protocols
The binding sites of miR-146a-5p and GPR17 were analyzed online using TargetScan [22 ] and microRNA.org. (http://www.microrna.org/microrna/getGeneForm.do). According to the complementary binding sites predicted by software, PCR amplification primers were designed and the GPR17 3′-UTR fragment (610 bp) containing miR-146a-5p sequence was constructed. Then, GPR17 3′-UTR fragment was cloned into the PGL3 dual-luciferase reporter vector (Promega, WI, U.S.A.), and named as GPR17-3′-UTR-WT. On the other hand, a single target site mutant GPR17-3′-UTR-MUT was constructed by using PCR technique for site-directed mutagenesis. SH-SY5Y cells were co-transfected with GPR17-3′-UTR-WT reporter vector or GPR17-3′-UTR-MUT reporter vector and miR-146a-5p mimic or miR-146a-5p inhibitor or NC by using Lipofectamine 2000 (Invitrogen). The cells were lysed after transfection for 24 h, and the luciferase activity was detected by double luciferase reporter (DLR) assay system following the manufacturer's instructions.
+ Open protocol
+ Expand
7

miR-222 Targets Integrin β8 3'-UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The program TargetScan (www.targetscan.org) was used to predict the target of miR-222. The wild-type and mutant integrin subunit β8 (ITGB8) 3′-UTR dual-luciferase reporter vectors were constructed by subcloning the human ITGB8 mRNA 3′-UTR and mutant 3′-UTR sequences into the pGL3 Dual-Luciferase Reporter Vectors (Promega Corporation). Cells were transfected with 80 ng luciferase reporter vectors and miR-222 mimics using the Lipofectamine 3000 (Invitrogen; Thermo Fisher Scientific, Inc.). After 24 h, luciferase activities were assessed using Dual-Luciferase Reporter System (Berthold Detection Systems GmbH) according to the manufacturer's instructions.
+ Open protocol
+ Expand
8

Promoter Activity Characterization Using Dual-Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to identify the promoter activity of HMR and downstream cryptic promoter regions, we constructed several PGL3 dual-luciferase reporter vectors (Promega, Madison, WI, USA) containing the target sequence for checking the promoter activity. Luciferase activity was determined 48 h after transfection as described earlier [42 (link)], by use of the dual-luciferase reporter assay system (Promega, Madison, USA) in duplicate samples, according to the protocol supplied by the manufacturer. Detailed protocol is included in the Supplementary Materials.
+ Open protocol
+ Expand
9

Verifying miR-338 and BIK Binding Relationship

Check if the same lab product or an alternative is used in the 5 most similar protocols
Referring to a previous report [28 (link)], the binding relationship between miR-338 and BIK was verified by a dual-luciferase assay. Potential binding sites between miR-338 and BIK were predicted in StarBase (http://starbase.sysu.edu.cn/). BIK 3ʹuntranslated region (3ʹUTR) fragments containing miR-338 binding sites were cloned into PGL3 dual-luciferase reporter vectors (Promega, Madison, WI, USA), thus constructing wild-type luciferase vectors (WT-3ʹUTR). Mutant luciferase vectors (MT-3ʹUTR) were constructed by mutating BIK binding sites. The recombinant plasmids were co-transfected with miR-338 mimic/inhibitor or its negative control into AGE1.HN and PC12 cells for 24 h. After a 10-min treatment with RIPA (Beyotime) at room temperature, the luciferase activity was measured with a luciferase assay kit (Promega, Madison, WI, USA) as described by the manufacturer.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!